Publications by authors named "Bradly H Strauss"
Article Synopsis
- The mitral valve (MV) is crucial in hypertrophic obstructive cardiomyopathy (HOCM), particularly in causing dynamic left ventricular outflow tract (LVOT) obstruction through systolic anterior motion (SAM).
- First-line treatment for HOCM is typically pharmacological, but surgical options may be necessary for patients who don’t respond to medication, especially given that standard therapies often fail to resolve mitral regurgitation (MR) associated with HOCM.
- Emerging therapies like transcatheter edge-to-edge repair (TEER) show promise in treating HOCM by modifying the mitral valve, helping reduce SAM and LVOT obstruction, with proposed algorithms for high-risk patients considering this intervention.
Takotsubo cardiomyopathy often presents to the cardiac catheterization laboratory masquerading as acute ST-elevation myocardial infarction (STEMI). Some of these patients present in shock secondary to dynamic left ventricular outflow tract (LVOT) obstruction. The typical patient is an elderly, hypertensive female with sigmoid deformity of the intraventricular septum.
View Article and Find Full Text PDF